Estrategias para reducir el tiempo de reperfusión en el tratamiento con angioplastia primaria

1994, Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients, Lancet, 343, 311, 10.1016/S0140-6736(94)91161-4 Weaver, 1997, Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review, JAMA, 278, 2093, 10.1001/jama.1997.03550230069040 Van de Werf, 2009, Guías de Práctica Clínica de la Sociedad Europea de Cardiología (ESC). Manejo del infarto agudo de miocardio en pacientes con elevación persistente del segmento ST, Rev Esp Cardiol, 62, e1 Antman, 2008, Circulation, 117, 296, 10.1161/CIRCULATIONAHA.107.188209 Keeley, 2003, Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials, Lancet, 361, 13, 10.1016/S0140-6736(03)12113-7 Zijlstra, 1997, Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction, J Am Coll Cardiol, 29, 908, 10.1016/S0735-1097(97)00018-1 Grines, 2003, Percutaneous transluminal coronary angioplasty. Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials, Am Heart J, 145, 47, 10.1067/mhj.2003.40 Herrmann, 2005, Transfer for primary angioplasthy: the importance of time, Circulation, 111, 718, 10.1161/01.CIR.0000156406.52178.C5 De Luca, 2003, Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty, J Am Coll Cardiol, 42, 991, 10.1016/S0735-1097(03)00919-7 De Luca, 2009, Retrasar el tratamiento equivale a negarlo, Rev Esp Cardiol, 62, 1, 10.1016/S0300-8932(09)70013-2 Ferreira-González, 2008, Estudio MASCARA (Manejo del Síndrome Coronario Agudo. Registro Actualizado). Resultados globales, Rev Esp Cardiol, 61, 803, 10.1157/13124991 Hasdai, 2002, A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS), Eur Heart J, 23, 1190, 10.1053/euhj.2002.3193 Nallamothu, 2007, Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention. The Global Registry of Acute Coronary Events, Heart, 93, 1552, 10.1136/hrt.2006.112847 Nallamothu, 2005, Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis; NRMI Investigators, Circulation, 111, 761, 10.1161/01.CIR.0000155258.44268.F8 Nallamothu, 2003, Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything?, Am J Cardiol, 92, 824, 10.1016/S0002-9149(03)00891-9 Betriu, 2005, Comparison of mortality rates in acute myocardial infarction treated by percutaneous coronary intervention versus fibrinolysis, Am J Cardiol, 95, 100, 10.1016/j.amjcard.2004.08.069 Pinto, 2006, Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy, Circulation, 114, 2019, 10.1161/CIRCULATIONAHA.106.638353 Boersma, 2006, Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients: The Primary Coronary Angioplasty vs. Thrombolysis Group, Eur Heart J, 27, 779, 10.1093/eurheartj/ehi810 Kent, 2007, Comparison of mortality benefit of immediate thrombolytic therapy versus delayed primary angioplasty for acute myocardial infarction, Am J Cardiol, 99, 1384, 10.1016/j.amjcard.2006.12.068 Magid, 2005, Relatioship between time of day, day of week, timeliness of reperfusion, and in-hospital mortality for patients with acute ST-segment elevation myocardial infarction, JAMA, 294, 803, 10.1001/jama.294.7.803 Bradley, 2006, Strategies for reducing the door-toballoon time in acute myocardial infarction, N Engl J Med, 355, 2308, 10.1056/NEJMsa063117 Nallamothu, 2007, Time to treatment in primary percutaneous coronary intervention, N Engl J Med, 357, 1631, 10.1056/NEJMra065985 Nallamothu, 2007, Development of systems of care for ST-elevation myocardial infarction. Patients: gaps, barriers, and implications, Circulation, 116, e68, 10.1161/CIRCULATIONAHA.107.184052 D2B. Sustain de Gain. Disponible en: http://www.d2balliance.org Jacobs, 2006, Recommendation to develop strategies to increase the number of ST-segment-elevation myocardial infarction patients with timely access to primary percutaneous coronary intervention, Circulation, 113, 2152, 10.1161/CIRCULATIONAHA.106.174477 Terkelsen, 2005, Reduction of treatment delay in patients with ST-elevation myocardial infarction: impact of pre-hospital diagnosis and direct referral to primary percutanous coronary intervention, Eur Heart J, 26, 770, 10.1093/eurheartj/ehi100 Widimský, 2003, Longdistance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction, Eur Heart J, 24, 94, 10.1016/S0195-668X(02)00468-2 Andersen, 2003, A Comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction, N Engl J Med, 349, 733, 10.1056/NEJMoa025142 Zijlstra, 2003, Angioplasty vs thrombolysis for acute myocardial infarction: a quantitative overview of the effects of interhospital transportation, Eur Heart J, 24, 21, 10.1016/S0195-668X(02)00693-0 Nallamothu, 2005, Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 Analysis, Circulation, 111, 761, 10.1161/01.CIR.0000155258.44268.F8 Manari, 2008, Clinical impact of an inter-hospital transfer strategy in patients with ST-elevation myocardial infarction undergoing primary angioplasty: the Emilia-Romagna ST-segment elevation acute myocardial infarction network, Eur Heart J, 29, 1834, 10.1093/eurheartj/ehn323 Ting, 2007, Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI Protocol, Circulation, 116, 729, 10.1161/CIRCULATIONAHA.107.699934 Aguirre, 2008, Rural interhospital transfer of ST-elevation myocardial infarction patients for percutaneous coronary revascularization: The Stat Heart Program, Circulation, 117, 1145, 10.1161/CIRCULATIONAHA.107.728519 Le May, 2008, A Citywide protocol for primary PCI in ST-segment elevation myocardial infarction, N Engl J Med, 358, 231, 10.1056/NEJMoa073102 Henry, 2007, A Regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction, Circulation, 116, 721, 10.1161/CIRCULATIONAHA.107.694141 Carrillo, 2002, Proyecto de un plan de accesibilidad al intervencionismo coronario en el infarto agudo de miocardio en la Región de Murcia (España). Registro APRIMUR, Rev Esp Cardiol, 55, 587, 10.1016/S0300-8932(02)76666-9 López-Palop, 2002, Intervalos de tiempo transcurridos en la realización de la angioplastia primaria: desde el inicio de los síntomas hasta la restauración del flujo, Rev Esp Cardiol, 55, 597, 10.1016/S0300-8932(02)76667-0 Carrillo, 2007, Tratamiento del infarto agudo de miocardio con angioplastia primaria in situ frente a transferencia interhospitalaria para su realización: resultados clínicos a corto y largo plazo, Rev Esp Cardiol, 60, 801, 10.1157/13108993 García, 1994, Angioplastia primaria en el infarto agudo de miocardio de localización anterior: resultados inmediatos, Rev Esp Cardiol, 47, 40 Mingo, 2009, Angioplastia primaria en nuestro medio. Análisis de los retrasos hasta la reperfusión, sus condicionantes y su implicación pronóstica, Rev Esp Cardiol, 62, 15, 10.1016/S0300-8932(09)70016-8